Orchid Pharma share price has zoomed 11% and is presently trading at Rs 1,290.0.
Meanwhile, the BSE HEALTHCARE index is at 38,160.5 (down 1.6%).
Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 2.6%) and ALEMBIC PHARMA (up 0.5%).
SUVEN PHARMACEUTICALS (down 6.4%) and Abbott India (down 4.5%) are among the top losers today.
Over the last one year, Orchid Pharma has moved up from Rs 565.8 to Rs 1,290.0, registering a gain of Rs 724.2 (up 128.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,443.1 to 38,160.5, registering a gain of 44.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 100.9%), Jubilant Pharmova (up 92.1%) and Lupin (up 91.4%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,606.3 (down 0.9%).
The top losers among the BSE Sensex today are Tata Steel (down 5.3%) and JSW Steel (down 4.4%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 24,526.6 (down 1.1%). Tata Steel and BPCL are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,589.9 to 80,606.3, registering a gain of 14,016.4 points (up 21.0%).
Orchid Pharma net profit fell 49.2% YoY to Rs 335 million for the quarter ended March 2024, compared to a profit of Rs 659 million a year ago. Net sales rose 3.4% to Rs 2,171 million during the period as against Rs 2,099 million in January-March 2023.
For the year ended March 2023, Orchid Pharma reported 197.1% increase in net profit to Rs 552 million compared to net loss of Rs 569 million during FY22. Revenue of the company grew 19.0% to Rs 6,659 million during FY23.
The current Price to earnings ratio of Orchid Pharma, based on rolling 12 month earnings, stands at 69.2.
Equitymaster requests your view! Post a comment on "Orchid Pharma Gains 11%; BSE HEALTHCARE Index Down 1.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!